|
Oct 10
|
Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of Autism
|
|
Jul 25
|
Marvel Biosciences Announces Stock Option Grants
|
|
Jul 24
|
Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett Syndrome
|
|
Jun 21
|
Marvel Biosciences Announces Private Placement Update
|